Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer put under the microscope. Cramer recalled his discussion with ...

A judge at Bridgeport Superior Court increased the verdict amount from &15 million to a total of $25 million on October. But ...

SC Johnson CEO Fisk Johnson laid out the business case for laws to control plastic waste. "Regulation is inevitable in my view. It's just a question of when." ...

On Wednesday, a Connecticut judge added $10 million in punitive damages against Johnson & Johnson after a jury's $15 million ...

An additional $10 million in punitive damages was awarded to Evan Plotkin in his asbestos-related lawsuit vs. Johnson & ...

A Connecticut judge has awarded an additional $10 million in punitive damages in asbestos-related lawsuit Evan Plotkin et al. v. Johnson & Johnson et al., bringing the […] ...

Nanobiotix (NBTX) stock rises as the firm reports 85% disease control in an early-stage trial for JNJ-1900, a cancer treatment developed with J&J (JNJ). Read more here.

Even though it’s been a terrible year for healthcare stocks, there are still a handful of real winners like Johnson and ...

This commitment to shareholder value has translated into exceptional market performance in 2025, with the stock delivering a ...

Johnson & Johnson, or J&J, is a Dividend King. That's an elite group of publicly listed companies in the U.S. that have increased their dividends for at least 50 consecutive years. This past April, ...

Johnson & Johnson's streak of dividend growth and its business prospects make the stock attractive. However, making ...